4//SEC Filing
Lamothe Jeffrey G. 4
Accession 0000950170-24-094816
CIK 0001671584other
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 4:33 PM ET
Size
10.3 KB
Accession
0000950170-24-094816
Insider Transaction Report
Form 4
Lamothe Jeffrey G.
EVP, COO
Transactions
- Exercise/Conversion
Common Stock
2024-08-08+42→ 894 total - Exercise/Conversion
Common Stock
2024-08-08+272→ 1,166 total - Exercise/Conversion
Restricted Stock Unit
2024-08-08−272→ 0 total→ Common Stock (272 underlying) - Exercise/Conversion
Restricted Stock Unit
2024-08-08−42→ 41 total→ Common Stock (42 underlying)
Footnotes (3)
- [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- [F2]On August 9, 2022, the reporting person was granted 5,500 (125 post-split) RSUs, vesting in three approximately equal annual installments beginning on August 8, 2023.
- [F3]On August 9, 2022, the reporting person was granted 23,958 (544 post-split) RSUs, vesting in two approximately equal annual installments beginning on August 8, 2023.
Documents
Issuer
Aptevo Therapeutics Inc.
CIK 0001671584
Entity typeother
Related Parties
1- filerCIK 0001679967
Filing Metadata
- Form type
- 4
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 4:33 PM ET
- Size
- 10.3 KB